Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)

Rael, C. T., Lopez-Ríos, J., McKenna, S. A., Das, D., Dolezal, C., Abascal, E., Carballo-Diéguez, A., Schnall, R., Hope, T. J., Bauermeister, J., & Bockting, W. (2021). Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP). AIDS and Behavior, 25(12), 4180–4192. https://doi.org/10.1007/s10461-021-03357-y
Authors:
Christine Tagliaferri Rael
Javier Lopez-Ríos
Stacey A. McKenna
Doyel Das
Curtis Dolezal
Elena Abascal
Alex Carballo-Diéguez
Rebecca Schnall
Thomas J. Hope
José Bauermeister
Walter Bockting
Affiliated Authors:
Christine Tagliaferri Rael
Javier Lopez-Ríos
Curtis Dolezal
Elena Abascal
Alex Carballo-Diéguez
Rebecca Schnall
Walter Bockting
Columbia Affiliation:
Author Keywords:
injectable cabotegravir
long-acting cabotegravir
prep
transgender women
elink
Publication Type:
Article
Unique ID:
10.1007/s10461-021-03357-y
PMID:
34216284
DOI:
10.1007/s10461-021-03357-y
Journal:
AIDS and Behavior
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: